CYTO logo

Altamira Therapeutics (CYTO) Interest Expense

Annual Interest Expense

$362.40 K
-$613.00 K-62.85%

01 December 2023

CYTO Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

N/A

01 June 2024

CYTO Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

N/A

01 June 2024

CYTO TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CYTO Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-62.9%--
3 y3 years+134.3%--
5 y5 years-66.7%--

CYTO Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-62.9%+2253.3%
5 y5 years-66.7%+2253.3%
alltimeall time-78.5%

Altamira Therapeutics Interest Expense History

DateAnnualQuarterlyTTM
Dec 2023
$362.40 K(-62.8%)
-
-
Dec 2022
$975.40 K(+6233.8%)
-
-
Dec 2021
$15.40 K(-90.0%)
-
-
Dec 2020
$154.70 K(+424.4%)
-
-
Dec 2019
$29.50 K(-97.3%)
-
-
Dec 2018
$1.09 M(-35.5%)
$89.20 K(-28.9%)
$1.09 M(-22.4%)
Sept 2018
-
$125.40 K(-75.3%)
$1.40 M(-17.7%)
June 2018
-
$508.40 K(+38.9%)
$1.71 M(+4.9%)
Mar 2018
-
$365.90 K(-9.2%)
$1.63 M(-3.3%)
Dec 2017
$1.68 M(+107.1%)
$403.10 K(-5.8%)
$1.68 M(+0.8%)
Sept 2017
-
$427.80 K(-0.3%)
$1.67 M(+0.6%)
June 2017
-
$429.10 K(+1.9%)
$1.66 M(+34.6%)
Mar 2017
-
$421.20 K(+8.2%)
$1.23 M(+51.5%)
Dec 2016
$813.20 K
$389.20 K(-7.0%)
$813.20 K(+91.0%)
DateAnnualQuarterlyTTM
Sept 2016
-
$418.60 K(>+9900.0%)
$425.70 K(+4737.5%)
June 2016
-
$2600.00(-7.1%)
$8800.00(-1.1%)
Mar 2016
-
$2800.00(+64.7%)
$8900.00(+8.5%)
Dec 2015
$8100.00(-85.6%)
$1700.00(0.0%)
$8200.00(+30.2%)
Sept 2015
-
$1700.00(-37.0%)
$6300.00(+6.8%)
June 2015
-
$2700.00(+28.6%)
$5900.00(-72.9%)
Mar 2015
-
$2100.00(-1150.0%)
$21.80 K(+10.7%)
Dec 2014
$56.40 K(-4.9%)
-$200.00(-115.4%)
$19.70 K(-1.0%)
Sept 2014
-
$1300.00(-93.0%)
$19.90 K(+7.0%)
June 2014
-
$18.60 K(+1966.7%)
$18.60 K(+55.0%)
Dec 2013
$59.30 K(>+9900.0%)
-
-
June 2013
-
$900.00(-91.9%)
$12.00 K(+8.1%)
Mar 2013
-
$11.10 K
$11.10 K
Dec 2012
$0.00
-
-

FAQ

  • What is Altamira Therapeutics annual interest expense?
  • What is the all time high annual interest expense for Altamira Therapeutics?
  • What is Altamira Therapeutics annual interest expense year-on-year change?
  • What is the all time high quarterly interest expense for Altamira Therapeutics?
  • What is the all time high TTM interest expense for Altamira Therapeutics?

What is Altamira Therapeutics annual interest expense?

The current annual interest expense of CYTO is $362.40 K

What is the all time high annual interest expense for Altamira Therapeutics?

Altamira Therapeutics all-time high annual interest expense is $1.68 M

What is Altamira Therapeutics annual interest expense year-on-year change?

Over the past year, CYTO annual interest expense has changed by -$613.00 K (-62.85%)

What is the all time high quarterly interest expense for Altamira Therapeutics?

Altamira Therapeutics all-time high quarterly interest expense is $508.40 K

What is the all time high TTM interest expense for Altamira Therapeutics?

Altamira Therapeutics all-time high TTM interest expense is $1.71 M